Welcome to PsychU!

Agitation

Agitation is a difficult behavioral issue for healthcare providers, caregivers and people with Alzheimer disease. In this library, we will bring you resources about current research, treatment interventions and other information.

Featured Resources

“Lighting Your Way”: A Digital Tool For Caregivers Of Loved Ones With The Behavioral Symptoms Of Dementia

“Lighting Your Way”: A Digital Tool For Caregivers Of Loved Ones With The Behavioral Symptoms Of Dementia

John Schall, Chief Executive Officer of Caregiver Action Network, chats with Dennis Sholler about “Lighting Your Way,” a new digital tool for caregivers of loved ones with the behavioral symptoms of dementia. During this interview, John walks through the “Lighting Your Way” digital tool on the Caregiver Action Network website….
New ICD-10 Codes For Dementia Agitation Go Into Effect October 1, 2022

New ICD-10 Codes For Dementia Agitation Go Into Effect October 1, 2022

Starting October 1, 2022, new International Classification of Disease, 10th Revision clinical modification (ICD-10 CM) codes go into effect to capture additional information on dementia conditions, including symptoms of dementia-related agitation. While previous codes identified types of dementia and whether behavioral disturbances were present, the new codes add specificity on…
A Conversation With An Expert In Agitation In Alzheimer’s Dementia, A Person With Lived Experience, & A Care Partner

A Conversation With An Expert In Agitation In Alzheimer’s Dementia, A Person With Lived Experience, & A Care Partner

Alzheimer’s dementia is highly prevalent, under-diagnosed, and predicted to increase significantly in the coming decades due to an aging population. Unfortunately, a large proportion of individuals with Alzheimer’s disease (AD) also experience neuropsychiatric symptoms, such as agitation, depression, apathy, and hallucinations. In this webinar, our panelist will be reviewing the…
The Neuropsychiatric Inventory: Development & Applications

The Neuropsychiatric Inventory: Development & Applications

Key Messages The Neuropsychiatric Inventory (NPI) is a reliable tool developed to capture a large scope of neuropsychiatric symptoms. NPI’s utility and applicability is global and show significant impact in clinical trials. The NPI has traversed clinical symptomatology and neurobiological data to provide key insights into the pathophysiology of neurodegenerative…
  • Mini-Cog™

    The Mini-Cog™ is a 3-minute instrument that can increase detection of cognitive impairment in older adults. It can be used…
  • Early Preclinical Alzheimer’s Disease Detectable Via Imaging

    Early preclinical Alzheimer’s disease is detectable via brain amyloid imaging. About 88% of cognitively normal older adults with elevated brain amyloid levels at…
Schizophrenia & Dementia Dual Diagnosis Increased After CMS Reporting Requirement For Nursing Home Antipsychotic Prescriptions

Schizophrenia & Dementia Dual Diagnosis Increased After CMS Reporting Requirement For Nursing Home Antipsychotic Prescriptions

After the Centers for Medicare and Medicaid Services’ (CMS) began requiring public reporting of nursing home antipsychotic use, the proportion of residents with different forms of dementia also diagnosed with schizophrenia increased. Between 2011 and 2017, the likelihood of having a schizophrenia diagnosis increased 1.9 percentage points among residents with…
High Childcare Stress Linked With Health Worker Burnout

High Childcare Stress Linked With Health Worker Burnout

Health care workers who reported high child care stress were 80% more likely to report experiencing burnout than health care workers not experiencing stress about child care responsibilities. Those who reported high levels of stress over personal child care responsibilities were more likely to experience burnout and express intentions to…

Upcoming Events

Advisors

  • Jeffrey Cummings, MD, ScD

    Agitation Section Advisor

Ask A Question About Agitation

Enter your question in the box below and click “Ask My Question” to submit your inquiry.

You must be logged in to ask a question in this section.

Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.

Caregiver Action Network

Caregiver Action Network (CAN) is the nation’s leading family caregiver organization working to improve the quality of life for the more than 90 million Americans who care for loved ones with chronic conditions, disabilities, disease, or the frailties of old age. CAN serves a broad spectrum of family caregivers ranging from the parents of children with significant health needs, to the families and friends of wounded soldiers; from a young couple dealing with a diagnosis of MS, to adult children caring for parents with Alzheimer’s disease.

Visit Website

REQUEST A PRESENTATION

Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.

Top Requested Presentations

The Neuropsychiatric Inventory: Development & Applications

Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR

Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Learning Tracks